|
Volumn 11, Issue 18, 2000, Pages 2453-2463
|
Eradication of breast cancer xenografts by hyperthermic suicide gene therapy under the control of the heat shock protein promoter
|
Author keywords
[No Author keywords available]
|
Indexed keywords
FAS ANTIGEN;
HEAT SHOCK PROTEIN;
ANIMAL CELL;
APOPTOSIS;
ARTICLE;
BREAST CARCINOMA;
CELL KILLING;
CHEMOSENSITIVITY;
CONTROLLED STUDY;
CYTOTOXICITY;
GENE CONTROL;
GENE THERAPY;
GENETIC TRANSFECTION;
HEAT SHOCK;
HEAT TOLERANCE;
HYPERTHERMIC THERAPY;
IMMUNOHISTOCHEMISTRY;
MOUSE;
NONHUMAN;
PROMOTER REGION;
PROTEIN EXPRESSION;
SUICIDE GENE;
TUMOR REGRESSION;
XENOGRAFT;
ANIMALS;
ANTIGENS, CD95;
ANTIVIRAL AGENTS;
APOPTOSIS;
BREAST NEOPLASMS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FAS LIGAND PROTEIN;
FEMALE;
GANCICLOVIR;
GENE THERAPY;
HEAT;
HEAT-SHOCK PROTEINS;
IMMUNOHISTOCHEMISTRY;
IN SITU NICK-END LABELING;
LIPOSOMES;
MAMMARY NEOPLASMS, ANIMAL;
MEMBRANE GLYCOPROTEINS;
MICE;
MICE, INBRED BALB C;
MICE, NUDE;
NEOPLASM TRANSPLANTATION;
PLASMIDS;
PROMOTER REGIONS (GENETICS);
RETROVIRIDAE;
TEMPERATURE;
THYMIDINE KINASE;
TIME FACTORS;
TISSUE DISTRIBUTION;
TRANSDUCTION, GENETIC;
TRANSFECTION;
TUMOR CELLS, CULTURED;
UP-REGULATION;
|
EID: 0034634857
PISSN: 10430342
EISSN: None
Source Type: Journal
DOI: 10.1089/10430340050207948 Document Type: Article |
Times cited : (57)
|
References (42)
|